# K230657: BTL-99-OC

- Pathway: 510(k) (Traditional)
- Applicant: BTL Industries, Inc.
- Decided: Feb 1, 2024 after 329 days
- Product code: QCI (Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder)
- Device class: 2
- Regulation: 21 CFR 882.5802
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to DEN070003 (2008). 16 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 18 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K193006: MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy system, Tonica Elektronik A/S (2020) Summary page 5.

## Most influential descendants
- K260691: BTL-699 (2026), 0 descendants of its own

## Indications for use
BTL-99-OC is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

Source page: https://510kreport.com/device/K230657
Methodology: https://510kreport.com/methodology